FDA Investigator Audrey J Yarbrough
Audrey J Yarbrough has conducted inspections on 18 sites in 2 countries as of 24 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
24 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Poland
FDA Investigators that have inspected at least one site in common with Audrey J Yarbrough:
Albert F Peacock, PhD,
Andrea A Branche,
Andrew R Wasko,
Anthony J Grace,
Anya Dlockett Evans,
Gene R Gunn,
Habacuc V Barrera,
Iris C Macinnes,
Joanne M Schlossin,
Joel D Martinez,
Ladislav Kermet,
Leighton Kn Gai,
Leon L Crawley,
Lillie M Young,
Patrick D Stone, MS,
Ruth E Medcalf,
Samantha J Pinizzotto, D V M,
Stacey F Rivette,
Tania Y Hall,
Terri E Gibson,
Travis M Beard
Audrey J Yarbrough's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2023 | FDA 483 | Edward Fox, M.D. - Form 483, 2023-03-24 |
September, 2023 | FDA 483 | University of Texas Medical Branch - Form 483, 2023-12-06 |
June, 2023 | FDA 483 | Ravi Ganeshappa, M.D. - Form 483, 2023-06-30 |
May, 2023 | FDA 483 | Vincent A. Restivo - Form 483, 2023-05-26 |
August, 2023 | FDA 483 | Stillmeadow Incorporated - Form 483, 2023-08-23 |
March, 2024 | FDA 483 | Marcelo V. Negrao, M.D. - Form 483, 2024-03-01 |
August, 2024 | FDA 483 | Christopher Romero, M.D. - Form 483, 2024-08-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more